Mobile Menu
Deals & Transactions

Conyers advises SELLAS Life Sciences Group Ltd on its continuance to Bermuda

October 2016 Guy Cooper

Conyers Dill & Pearman advised SELLAS Life Sciences Group Ltd, on the continuation of the company from Zug, Switzerland to Bermuda. SELLAS is a late-stage biopharmaceutical firm which is focused on the development of novel products to treat a variety of cancers using the body’s own defences. The company has a close working relationship with the Memorial Sloan-Kettering Cancer Center in New York to progress research and trials for treatment on various types of cancer.

Guy Cooper from the Bermuda office of Conyers Dill & Pearman worked on the matter.


Guy Cooper

Bermuda   +1 441 299 4938


"Few firms can come close to Conyers on one critical metric, and this is the breadth of the client base."
- IFLR1000